645
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Epidemiology of Community Origin Escherichia coli and Klebsiella pneumoniae Uropathogenic Strains Resistant to Antibiotics in Franceville, Gabon

, ORCID Icon, , ORCID Icon, ORCID Icon, , , & ORCID Icon show all
Pages 585-594 | Published online: 16 Feb 2021

References

  • Gonzalez CM, Schaeffer AJ. Treatment of urinary tract infection: what’s old, what’s new, and what works. World J Urol. 1999;17(6):372–382. doi:10.1007/s00345005016310654368
  • Gajdacs M, Batori Z, Abrok M, Lazar A, Burian K. Characterization of resistance in gram-negative urinary isolates using existing and novel indicators of clinical relevance: a 10-year data analysis. Life. 2020;10(2):16. doi:10.3390/life10020016
  • WHO. Système mondial de surveillance de la résistance aux antimicrobiens: Manual de mise en oeuvre initiale. Zurich: World Health Organization; 2016.
  • Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000–2009). BMC Infect Dis. 2013;13:19. doi:10.1186/1471-2334-13-1923327474
  • Gajdacs M, Burian K, Terhes G. Resistance levels and epidemiology of non-fermenting gram-negative bacteria in urinary tract infections of inpatients and outpatients (RENFUTI): a 10-year epidemiological snapshot. Antibiotics. 2019;8(3).
  • Gajdacs M, Doczi I, Abrok M, Lazar A, Burian K. Epidemiology of candiduria and Candida urinary tract infections in inpatients and outpatients: results from a 10-year retrospective survey. Cent Eur J Urol. 2019;72(2):209–214. doi:10.5173/ceju.2019.1909
  • Sire JM, Nabeth P, Perrier-Gros-Claude JD, et al. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal. J Infect Dev Ctries. 2007;1(3):263–268. doi:10.3855/jidc.36219734603
  • SPILF. Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires de l’adulte. Paris: SPILF; 2015:1–43.
  • Gajdacs M, Albericio F. Antibiotic resistance: from the bench to patients. Antibiotics. 2019;8(3):129. doi:10.3390/antibiotics8030129
  • De Francesco MA, Ravizzola G, Peroni L, Negrini R, Manca N. Urinary tract infections in Brescia, Italy: etiology of uropathogens and antimicrobial resistance of common uropathogens. Med Sci Monit. 2007;13(6):BR136–44.17534228
  • Neto JAD, Martins ACP, Silva LDMD. Community acquired urinary tract infection: etiology and bacterial susceptibility. Acta Cir Bras. 2003;18(suppl 5):33–36. doi:10.1590/S0102-86502003001200012
  • Hay AD, Birnie K, Busby J, Delaney B, Downing H, Dudley J. The diagnosis of urinary tract infection in young children (DUTY): a diagnostic prospective observational study to derive and validate a clinical algorithm for the diagnosis of urinary tract infection in children presenting to primary care with an acute illness. Health Technol Assess (Rockv). 2016;20(51):1–294. doi:10.3310/hta20510
  • SFM/EUCAST. Comité de l’Antibiogramme de la Sociéte Française de Microbiologie: recommandations. Paris; 2018 Available from: https://www.sfm-microbiologie.org/wp-content/uploads/2018/12/CASFMV2_SEPTEMBRE2018.pdf. Accessed 29, 2021.
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
  • El Bouamri MC, Arsalane L, Kamouni Y, et al. Current antibiotic resistance profile of uropathogenic Escherichia coli strains and therapeutic consequences. Prog Urol. 2014;24(16):1058–1062.25310915
  • Nzalie RN, Gonsu HK, Koulla-Shiro S. Bacterial etiology and antibiotic resistance profile of community-acquired urinary tract infections in a cameroonian city. Int J Microbiol. 2016;2016:3240268. doi:10.1155/2016/324026827667998
  • El-Mahmood MA. Antimicrobial susceptibility pattern of pathogenic bacteria causing urinary tract infections at the Specialist Hospital, Yola, Adamawa state, Nigeria. J Clin Med Res. 2009;1(1):1–8.22505957
  • Yandai FH, Ndoutamia G, Nadlaou B, Barro N. Prevalence and resistance profile of Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in N’Djamena, Tchad. Int J Biol Chem Sci. 2019;13(4):2065–2073. doi:10.4314/ijbcs.v13i4.13
  • Randrianirina F, Soares JL, Carod JF, et al. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. J Antimicrob Chemother. 2007;59(2):309–312. doi:10.1093/jac/dkl46617138569
  • Muvunyi CM, Masaisa F, Bayingana C, et al. Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: need for new antimicrobial guidelines. Am J Trop Med Hyg. 2011;84(6):923–928. doi:10.4269/ajtmh.2011.11-005721633029
  • Arsalane L, Kamouni Y, Yahyaoui H, Bennouar N, Berraha M, Zouhair S. Profil actuel de résistance aux antibiotiques des souches d’Escherichia coli uropathogènes et conséquences thérapeutiques. Prog Urol. 2014;24(16):1058–1062. doi:10.1016/j.purol.2014.09.03525310915
  • Gonsu Kamga H, Nzengang R, Toukam M, Sando Z, Koulla Shiro S. Phénotypes de résistance des souches d’Escherichia coli responsables des infections urinaires communautaires dans la ville de Yaoundé (Cameroun). Afr J Pathol Microbiol. 2014;3:1–4. doi:10.4303/ajpm/235891
  • Kolawole AS, Kolawole OM, Kandaki-Olukemi YT, Babatunde SK, Durowade KA, Kolawole CF. Prevalence of urinary tract infections (UTI) among patients attending Dalhatu Araf Specialist Hospital, Lafia, Nasarawa state, Nigeria. Int J Med Sci. 2010;1(5):163–167.
  • Behzadi P, Urban E, Matuz M, Benko R, Gajdacs M. The role of gram-negative bacteria in urinary tract infections: current concepts and therapeutic options. Adv Exp Med Biol. 2020.
  • Chang SL, Shortliffe LD. Pediatric urinary tract infections. Pediatr Clin North Am. 2006;53(3):379–400. doi:10.1016/j.pcl.2006.02.01116716786
  • Bernabe KJ, Langendorf C, Ford N, Ronat J-B, Murphy RA. Antimicrobial resistance in West Africa: a systematic review and meta-analysis. Int J Antimicrob Agents. 2017;50(5):629–639. doi:10.1016/j.ijantimicag.2017.07.00228705671
  • Hima-Lerible H, Menard D, Talarmin A. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Bangui, Central African Republic. J Antimicrob Chemother. 2003;51(1):192–194. doi:10.1093/jac/dkg05312493816
  • Benhiba I, Bouzekraoui T, Zahidi J. Epidémiologie et antibio-résistance des infections urinaires à entérobactéries chez l’adulte dans le CHU de Marrakech et implication thérapeutique. Revue Africaine. 2015;1(4).
  • Dia ML, Chabouny H, Diagne R. Profil antibiotypique des bactéries uropathogènes isolées au CHU de Dakar. Revue Africaine. 2015;1(4).
  • Ullah F, Malik SA, Ahmed J. Antimicrobial susceptibility pattern and ESBL prevalence in Klebsiella pneumoniae from urinary tract infections in the North-West of Pakistan. Afr J Microbiol Res. 2009;3(11):676–680.
  • Ahmed AA, Osman H, Mansour AM, et al. Antimicrobial agent resistance in bacterial isolates from patients with diarrhea and urinary tract infection in the Sudan. Am J Trop Med Hyg. 2000;63(5–6):259–263. doi:10.4269/ajtmh.2000.63.25911421374
  • Singh NP, Goyal R, Manchanda V, Das S, Kaur I, Talwar V. Changing trends in bacteriology of burns in the burns unit, Delhi, India. Burns. 2003;29(2):129–132. doi:10.1016/S0305-4179(02)00249-812615458
  • Schaumburg F, Alabi A, Kokou C, et al. High burden of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Gabon. J Antimicrob Chemother. 2013;68(9):2140–2143. doi:10.1093/jac/dkt16423645586
  • Yala J-F, Mabika Mabika R, Bisseye C, et al. Phenotypic and genotypic characterization of extended-spectrum-beta-lactamases producing-enterobacteriaceae (ESBLE) in patients attending Omar Bongo Ondimba military hospital at Libreville (Gabon). J Mol Microbiol Biotechnol. 2016;4(6):944–949.
  • WHO. Antimicrobial Resistance: Global Report on Surveillance: World Health Organization. 2014.
  • Leopold SJ, van Leth F, Tarekegn H, Schultsz C. Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review. J Antimicrob Chemother. 2014;69(9):2337–2353. doi:10.1093/jac/dku17624879668
  • Dromigny JA, Nabeth P. Distribution and susceptibility of bacterial urinary tract infections in Dakar, Senegal. Int J Antimicrob Agents. 2002;20(5):339–347. doi:10.1016/S0924-8579(02)00196-612431869
  • Naziri Z, Derakhshandeh A, Soltani Borchaloee A, Poormaleknia M, Azimzadeh N. Treatment failure in urinary tract infections: a warning witness for virulent multi-drug resistant ESBL- producing escherichia coli. Infect Drug Resist. 2020;13:1839–1850. doi:10.2147/IDR.S25613132606833
  • Radyowijati A, Haak H. Improving antibiotic use in low-income countries: an overview of evidence on determinants. Soc Sci Med. 2003;57(4):733–744. doi:10.1016/S0277-9536(02)00422-712821020
  • Tadesse BT, Ashley EA, Ongarello S, et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis. 2017;17(1):616. doi:10.1186/s12879-017-2713-128893183
  • Grigoryan L, Burgerhof JG, Haaijer-Ruskamp FM, et al. Is self-medication with antibiotics in Europe driven by prescribed use? J Antimicrob Chemother. 2007;59(1):152–156. doi:10.1093/jac/dkl45717124192
  • Planta MB. The role of poverty in antimicrobial resistance. J Am Board Fam Med. 2007;20(6):533–539. doi:10.3122/jabfm.2007j.06.07001917954860